Discover Community Create You

Loading publication...

Noodle always counts identifier-free feature events for service operation. With your permission, Google Analytics can also estimate audience and engagement. Search text, publication identifiers, cookies, IP addresses and browser fingerprints are never included in Noodle's first-party event counters.

Privacy details

Article

Cutaneous Rosai Dorfman disease harboring RET and MAP2K1 mutations, successfully treated with methotrexate.

International journal of dermatology - 1 Nov 2022

Konstantinou Maria P, Tournier Emilie

Abstract excerpt

No abstract is available from the source.

Read the complete abstract on PubMed

Topics

Share this publication in a Topic to start or enrich a Post.

Share to MAP Kinase Kinase 1
Share to Methotrexate
Share to Mutation
Share to Proto-Oncogene Proteins c-ret

Methodology Data sources Editorial policy Privacy About Contact Helena Bioinformatics

Share to Skin Diseases

Source

Open in PubMed Open full text

Identifiers

PMID: 35569068
DOI: 10.1111/ijd.16269
PMCID: PMC9790644

Provenance

PubMed metadata and Literature Corpus relationships. Corpus snapshot updated 7 Sept 2026.

Related research

Semantic proximity does not establish scientific evidence.

Research trail→

Click a neighbor to travelStep 1 · 12 closest

Cutaneous Rosai Dorfman disease harboring RET and MAP2K1 mutations, successfully treated with methotrexate.PMID 35569068Read ↗

Clinicopathological features, treatment approaches, and outcomes in Rosai-Dorfman disease.Semantic proximity Read ↗

Activating MAPK1 (ERK2) mutation in an aggressive case of disseminated juvenile xanthogranulomaSemantic proximity Read ↗

Erdheim–Chester Disease: Comprehensive Review of Molecular Profiling and Therapeutic AdvancesSemantic proximity Read ↗

Cutaneous Rosai-Dorfman disease with MAP2K1 mutation, initially mimicking an infection with parasitized histiocytes.Semantic proximity Read ↗

Refractory juvenile xanthogranuloma of the mastoid bone responsive to trametinibSemantic proximity Read ↗

Erdheim-Chester Disease: A Case Report of BRAF V600E-Negative, MAP2K1-Positive ECD Diagnosed by Blood Next-Generation Sequencing Assay and a Brief Literature Review.Semantic proximity Read ↗

Mutually exclusive recurrent KRAS and MAP2K1 mutations in Rosai-Dorfman disease.Semantic proximity Read ↗

The clinical presentation of DFNB2.Semantic proximity Read ↗

[Cutaneous Rosai-Dorfman disease with lack of BRAF-V600, KRAS or NRAS mutations: A reactive or neoplastic disorder?]Semantic proximity Read ↗

Clinical presentation of DFNB1.Semantic proximity Read ↗

Treatment of Langerhans Cell Histiocytosis and Histiocytic Disorders: A Focus on MAPK Pathway Inhibitors.Semantic proximity Read ↗

Trametinib for a child with refractory Rosai-Dorfman-Destombes disease harboring a novel somatic mutation in MAP2K1.Semantic proximity Read ↗

⌁Select a neighboring publication to make it the new centre.